This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hammond, A. L.
Right arrow Articles by Cattaneo, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hammond, A. L.
Right arrow Articles by Cattaneo, R.

 Previous Article  |  Next Article 

Journal of Virology, March 2001, p. 2087-2096, Vol. 75, No. 5
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.5.2087-2096.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Single-Chain Antibody Displayed on a Recombinant Measles Virus Confers Entry through the Tumor-Associated Carcinoembryonic Antigen

Anthea L. Hammond, Richard K. Plemper, Jie Zhang, Urs Schneider, Stephen J. Russell, and Roberto Cattaneo*

Molecular Medicine Program, Mayo Foundation, Rochester, Minnesota 55905

Received 21 September 2000/Accepted 29 November 2000

To redirect the tropism of the vaccine strain of measles virus (MV), Edmonston B, to a targeted cell population, we displayed on the viral hemagglutinin (H) a single-chain antibody (scAb) specific for the tumor-associated carcinoembryonic antigen (CEA). We generated H fusion proteins with three forms of the scAb appended, differing in the lengths of the linkers separating the VH and VL domains and thus in the oligomerization states of the scAbs. All proteins were stable, appeared properly folded, and were transported to the cell surface, but only H displaying the long-linker form of scAb was functional in supporting cell-cell fusion. This protein induced extensive syncytia in cells expressing the normal virus receptor CD46 and also in CD46-negative cells expressing the targeted receptor, human CEA. Replication-competent MV with H replaced by H displaying the long-linker form of scAb was recovered and replicated efficiently in both CD46-positive and CD46-negative, CEA-positive cells. Thus, MV not only tolerates the addition of a scAb on its H protein but also infects cells via a novel interaction between the scAb and its targeted receptor.

* Corresponding author. Mailing address: Molecular Medicine Program, Mayo Foundation, 200 First St. SW, Rochester, MN 55905. Phone: (507) 284-0171. Fax: (507) 266-2122. E-mail: cattaneo.roberto{at}mayo.edu.

Journal of Virology, March 2001, p. 2087-2096, Vol. 75, No. 5
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.5.2087-2096.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Jing, Y., Tong, C., Zhang, J., Nakamura, T., Iankov, I., Russell, S. J., Merchan, J. R. (2009). Tumor and Vascular Targeting of a Novel Oncolytic Measles Virus Retargeted against the Urokinase Receptor. Cancer Res. 69: 1459-1468 [Abstract] [Full Text]  
  • Gainey, M. D., Manuse, M. J., Parks, G. D. (2008). A Hyperfusogenic F Protein Enhances the Oncolytic Potency of a Paramyxovirus Simian Virus 5 P/V Mutant without Compromising Sensitivity to Type I Interferon. J. Virol. 82: 9369-9380 [Abstract] [Full Text]  
  • Ungerechts, G., Springfeld, C., Frenzke, M. E., Lampe, J., Johnston, P. B., Parker, W. B., Sorscher, E. J., Cattaneo, R. (2007). Lymphoma Chemovirotherapy: CD20-Targeted and Convertase-Armed Measles Virus Can Synergize with Fludarabine. Cancer Res. 67: 10939-10947 [Abstract] [Full Text]  
  • Yanagi, Y., Takeda, M., Ohno, S. (2006). Measles virus: cellular receptors, tropism and pathogenesis.. J. Gen. Virol. 87: 2767-2779 [Abstract] [Full Text]  
  • Gao, Y., Whitaker-Dowling, P., Watkins, S. C., Griffin, J. A., Bergman, I. (2006). Rapid adaptation of a recombinant vesicular stomatitis virus to a targeted cell line.. J. Virol. 80: 8603-8612 [Abstract] [Full Text]  
  • Springfeld, C., von Messling, V., Frenzke, M., Ungerechts, G., Buchholz, C. J., Cattaneo, R. (2006). Oncolytic efficacy and enhanced safety of measles virus activated by tumor-secreted matrix metalloproteinases.. Cancer Res. 66: 7694-7700 [Abstract] [Full Text]  
  • Verheije, M. H., Wurdinger, T., van Beusechem, V. W., de Haan, C. A. M., Gerritsen, W. R., Rottier, P. J. M. (2006). Redirecting Coronavirus to a Nonnative Receptor through a Virus-Encoded Targeting Adapter. J. Virol. 80: 1250-1260 [Abstract] [Full Text]  
  • Heinzerling, L., Kunzi, V., Oberholzer, P. A., Kundig, T., Naim, H., Dummer, R. (2005). Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells. Blood 106: 2287-2294 [Abstract] [Full Text]  
  • Springfeld, C., von Messling, V., Tidona, C. A., Darai, G., Cattaneo, R. (2005). Envelope Targeting: Hemagglutinin Attachment Specificity Rather than Fusion Protein Cleavage-Activation Restricts Tupaia Paramyxovirus Tropism. J. Virol. 79: 10155-10163 [Abstract] [Full Text]  
  • Horn, G. P., Vongpunsawad, S., Kornmann, E., Fritz, B., Dittmer, D. P., Cattaneo, R., Dobbelstein, M. (2005). Enhanced Cytotoxicity without Internuclear Spread of Adenovirus upon Cell Fusion by Measles Virus Glycoproteins. J. Virol. 79: 1911-1917 [Abstract] [Full Text]  
  • Schlehuber, L. D., Rose, J. K. (2004). Prediction and Identification of a Permissive Epitope Insertion Site in the Vesicular Stomatitis Virus Glycoprotein. J. Virol. 78: 5079-5087 [Abstract] [Full Text]  
  • Vongpunsawad, S., Oezgun, N., Braun, W., Cattaneo, R. (2004). Selectively Receptor-Blind Measles Viruses: Identification of Residues Necessary for SLAM- or CD46-Induced Fusion and Their Localization on a New Hemagglutinin Structural Model. J. Virol. 78: 302-313 [Abstract] [Full Text]  
  • Peng, K.-W., Donovan, K. A., Schneider, U., Cattaneo, R., Lust, J. A., Russell, S. J. (2003). Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker. Blood 101: 2557-2562 [Abstract] [Full Text]  
  • Peng, K.-W., TenEyck, C. J., Galanis, E., Kalli, K. R., Hartmann, L. C., Russell, S. J. (2002). Intraperitoneal Therapy of Ovarian Cancer Using an Engineered Measles Virus. Cancer Res. 62: 4656-4662 [Abstract] [Full Text]  
  • Moll, M., Klenk, H.-D., Maisner, A. (2002). Importance of the Cytoplasmic Tails of the Measles Virus Glycoproteins for Fusogenic Activity and the Generation of Recombinant Measles Viruses. J. Virol. 76: 7174-7186 [Abstract] [Full Text]  
  • Christiansen, D., De Sousa, E. R., Loveland, B., Kyriakou, P., Lanteri, M., Wild, F. T., Gerlier, D. (2002). A CD46CD[55-46] chimeric receptor, eight short consensus repeats long, acts as an inhibitor of both CD46 (MCP)- and CD150 (SLAM)-mediated cell-cell fusion induced by CD46-using measles virus. J. Gen. Virol. 83: 1147-1155 [Abstract] [Full Text]  
  • Plemper, R. K., Hammond, A. L., Gerlier, D., Fielding, A. K., Cattaneo, R. (2002). Strength of Envelope Protein Interaction Modulates Cytopathicity of Measles Virus. J. Virol. 76: 5051-5061 [Abstract] [Full Text]  
  • Ring, C. J. A. (2002). Cytolytic viruses as potential anti-cancer agents. J. Gen. Virol. 83: 491-502 [Abstract] [Full Text]  
  • Peng, K.-W., Ahmann, G. J., Pham, L., Greipp, P. R., Cattaneo, R., Russell, S. J. (2001). Systemic therapy of myeloma xenografts by an attenuated measles virus. Blood 98: 2002-2007 [Abstract] [Full Text]  
  • Grote, D., Russell, S. J., Cornu, T. I., Cattaneo, R., Vile, R., Poland, G. A., Fielding, A. K. (2001). Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice. Blood 97: 3746-3754 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»